黑料网

Diabetes is a chronic disease affecting more than 38 million Americans (over 1 in 10) with nearly 100 million (nearly 1 in 3) having prediabetes and high lifetime risk of diabetes[1]. Overweight and obesity are major drivers of the epidemic of diabetes and now impacts the majority of both children and adults in the United States (US). Diabetes and obesity are major contributors to essentially all the chief causes of death and disability in the US including cancer, heart disease, stroke, dementia, psychiatric disorders, lung disease, arthritis, chronic pain and birth defects. Together, they are fundamental drivers of poor health and enormous costs to our nation.

Other endocrine disorders affect everything from fertility to hair growth, from bone strength to complexion and comprise hundreds of conditions, rare and common. 黑料网 Health, 黑料网 and the University have had enormous impact and continue to lead the development of new approaches, drugs, devices and diagnostics in the field.

黑料网 conducts basic science, translational science, clinical trials, population science, and policy work in many endocrine disorders but has global impact in diabetes, obesity, bone health and pituitary diseases. The CRA has specific partnerships to develop innovative multicenter trials aimed to further advance treatment and prevention of diabetes, obesity and other metabolic and endocrine disorders.